Speciated High-Density Lipoprotein Biogenesis and Functionality | JoVE Visualize

Area of Science:

Biochemistry
Cardiovascular Medicine
Lipid Metabolism

Background:

Plasma high-density lipoprotein cholesterol (HDL-C) is a recognized negative risk factor for atherosclerotic cardiovascular disease (CVD).
Despite the established link, therapeutic strategies aimed at increasing HDL-C levels have largely failed to demonstrate cardioprotective benefits.
Current research emphasizes HDL functionality and quality over mere quantity in its atheroprotective role.

Purpose of the Study:

To review and provide a perspective on speciated high-density lipoprotein (HDL) biogenesis.
To explore the factors influencing HDL function beyond cholesterol concentration, focusing on stability and composition.
To discuss the implications of HDL heterogeneity in health and disease.

Main Methods:

Literature review and synthesis of current knowledge on HDL biogenesis, composition, and function.
Analysis of factors such as HDL subclass stability, apolipoprotein content (apo AI, apo AII), and other associated proteins.
Discussion of the role of specific HDL species, including those with intact signal peptides, in cholesterol transport and beyond.

Main Results:

HDL function, particularly its role in reverse cholesterol transport, is impaired in patients with CVD, independent of HDL-C levels.
HDL stability and composition, including the presence and ratio of apolipoproteins (apo AI, apo AII) and other proteins, are key determinants of HDL function.
Heterogeneity exists within HDL particles, with distinct subclasses and species exhibiting unique properties and potential roles in health and disease.

Conclusions:

The focus on HDL quality, including its functional capacity, stability, and specific composition, is more relevant for cardioprotection than HDL-C quantity alone.
Understanding the biogenesis and heterogeneity of specific HDL species is critical for elucidating their precise roles in cardiovascular health and disease.
Further research into the functional implications of diverse HDL subclasses and their associated proteins may reveal novel therapeutic targets for CVD.